Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Current Leases (2019 - 2025)

Apyx Medical's Current Leases history spans 7 years, with the latest figure at $407000.0 for Q4 2025.

  • For Q4 2025, Current Leases rose 21.49% year-over-year to $407000.0; the TTM value through Dec 2025 reached $407000.0, up 21.49%, while the annual FY2025 figure was $407000.0, 21.49% up from the prior year.
  • Current Leases reached $407000.0 in Q4 2025 per APYX's latest filing, up from $393000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $407000.0 in Q4 2025 to a low of $20000.0 in Q3 2023.
  • Average Current Leases over 5 years is $151350.0, with a median of $120500.0 recorded in 2021.
  • Peak YoY movement for Current Leases: tumbled 94.07% in 2024, then soared 1865.0% in 2025.
  • A 5-year view of Current Leases shows it stood at $165000.0 in 2021, then soared by 30.91% to $216000.0 in 2022, then crashed by 90.74% to $20000.0 in 2023, then surged by 1575.0% to $335000.0 in 2024, then rose by 21.49% to $407000.0 in 2025.
  • Per Business Quant, the three most recent readings for APYX's Current Leases are $407000.0 (Q4 2025), $393000.0 (Q3 2025), and $20000.0 (Q2 2025).